Follow-The-Filings

Security · featured owners

AUTL Autolus Therapeutics PLC

Health Care SPON ADS Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $287K

AUTL (Autolus Therapeutics PLC) is held in 1 featured 13F book as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.05%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel 0.05%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.05% Hold 179,316 $287K history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $75.39M
Gross profit * — — -$20.98M
Gross margin * — — -27.8%
Net income -$208.38M -$220.66M -$287.53M
Net margin * — — -381.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $393.88M $660.93M $435.92M
Total non-current assets * $66.09M $121.8M $153.15M
Total assets $459.97M $782.72M $589.07M
Total current liabilities $39.64M $60.74M $73.44M
Total non-current liabilities * $153.41M $294.66M $337.5M
Total equity $266.92M $427.32M $178.13M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$145.59M -$206.27M -$283.57M
Cash from investing -$10.99M -$394.55M $158.46M
Cash from financing -$0.883M $589.55M -$4.34M
Net change in cash -$142.43M -$11.53M -$123.17M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders